A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma

Glioblastoma is the most malignant tumor and has high mortality rate. The methylated prompter of MGMT results in chemotherapy sensitivity for these patients. However, there are still other factors that affected the prognosis for the glioblastoma patients with similar MGMT methylation status. We deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen, Zhang, Lu, Wang, Zheng, Yang, Fan, Wang, Haoyuan, Liang, Tingyu, Wu, Fan, Lan, Qing, Wang, Jiangfei, Zhao, Jizong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342529/
https://www.ncbi.nlm.nih.gov/pubmed/27588397
http://dx.doi.org/10.18632/oncotarget.11726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342529/
https://www.ncbi.nlm.nih.gov/pubmed/27588397
http://dx.doi.org/10.18632/oncotarget.11726

Ejemplares similares